• Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • GMA3: WYNTK
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Do Not Sell My Info
  • Contact Us
  • © 2025 ABC News
  • Wellness

Semaglutide used for weight loss also helps reduce heart failure symptoms, study finds

1:53
Medication used in weight loss drugs may help heart failure
Florian Gaertner/Photothek via Getty Images
ByKatie Kindelan
August 28, 2023, 4:16 PM

Semaglutide, the active ingredient in drugs like Wegovy and Ozempic, is also effective at reducing symptoms of heart failure, new research shows.

A study published this month in the New England Journal of Medicine followed over 500 patients who were both overweight and had a specific type of heart failure known as heart failure with preserved ejection fraction.

Over the course of one year of taking weekly injections of semaglutide, the patients not only lost weight but also had significant reductions in symptoms of heart failure and saw an improvement in their ability to exercise, according to the study.

Heart failure, or congestive heart failure, happens when your heart doesn’t pump enough blood to meet the needs of your body, according to the National Institutes of Health. It impacts more than 6 million adults in the United States, meaning an accessible treatment for the condition could have widespread impact. About half of patients with heart failure have the specific kind this study looked at.

Likewise, the potential success of semaglutide in improving heart health could transform the compound's popularity even further.

PHOTO: A Semaglutide pill photo illustration.
STOCK PHOTO/Getty Images

Interest in semaglutide has surged over the past year for its role in helping people lose weight.

Obesity is a condition that affects nearly 42% of the population and is associated with over $170 billion in medical costs in the U.S., according to the Centers for Disease Control and Prevention.

Novo Nordisk, the company that funded the most recent study, makes both Wegovy and Ozempic, the two most popular drugs that have semaglutide as the active ingredient.

Related Articles

MORE: FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy

The U.S. Food and Drug Administration has approved Ozempic as a treatment for Type 2 diabetes -- a chronic condition in which the body doesn't respond well to insulin -- alongside diet and exercise if other medications cannot control blood sugar levels well enough.

Editor’s Picks

FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy

  • Jun 01, 2023

Popular diabetes drug Mounjaro shows weight loss results in new study

  • Apr 27, 2023

Ozempic weight loss pills may be on the way

  • Jun 26, 2023

Although Ozempic is not explicitly approved for chronic weight management, it can be prescribed off-label and used safely for people who are obese.

The anti-diabetic medication Ozempic is pictured in a pharmacy on April 13, 2023.
Florian Gaertner/Photothek via Getty Images

Wegovy is essentially the same injectable drug as Ozempic prescribed at a higher dosage. The FDA has specifically approved Wegovy for patients with severe obesity, or who are overweight and have one or more weight-associated conditions like high blood pressure or high cholesterol.

Both drugs work by slowing down movement of food through the stomach and curbing appetite, thereby causing weight loss.

Related Articles

MORE: First came Ozempic for weight loss, then came the shaming.

Earlier this month, Novo Nordisk released preliminary results of a study that found Wegovy also helped lower the risk of heart attacks and strokes, according to the company.

Wegovy lowered the risk of major cardiovascular events by 20% in a clinical trial that included over 17,000 adults ages 45 and older who have a history of cardiovascular disease and are overweight or obese, according to the Novo Nordisk-funded study.

As a result of the trial's findings, Novo Nordisk said it plans to file for a "label indication expansion" for the drug, meaning it could be available beyond obesity, and with greater insurance coverage.

Without insurance coverage, the cost of medications like Wegovy and Ozempic can run more than $1,000 a month.

Editor’s Picks

FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy

  • Jun 01, 2023

Popular diabetes drug Mounjaro shows weight loss results in new study

  • Apr 27, 2023

Ozempic weight loss pills may be on the way

  • Jun 26, 2023

Up Next in Wellness—

Weight-loss meds may give people more control over drinking, study shows

May 9, 2025

3 Doors Down frontman announces Stage 4 cancer diagnosis

May 8, 2025

Women's Health Initiative to continue after threat of funding cuts, researchers say

May 7, 2025

Try this doctor-approved smoothie for energy, immunity and heart health

May 1, 2025

Shop GMA Favorites

ABC will receive a commission for purchases made through these links.

Sponsored Content by Taboola

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Info
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • Shop FAQs
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap

© 2025 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Do Not Sell My Info— 
  • Contact Us— 

© 2025 ABC News